These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 1383385)

  • 1. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
    Khoury SJ; Hancock WW; Weiner HL
    J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
    Miller A; Lider O; Roberts AB; Sporn MB; Weiner HL
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):421-5. PubMed ID: 1370356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
    Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL
    J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines.
    Maron R; Slavin AJ; Hoffmann E; Komagata Y; Weiner HL
    Int Immunol; 2002 Feb; 14(2):131-8. PubMed ID: 11809732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
    Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
    Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
    Santos LM; al-Sabbagh A; Londono A; Weiner HL
    Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-driven bystander suppression after oral administration of antigens.
    Miller A; Lider O; Weiner HL
    J Exp Med; 1991 Oct; 174(4):791-8. PubMed ID: 1717632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
    Chen Y; Inobe J; Weiner HL
    J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression.
    Sun JB; Xiao BG; Lindblad M; Li BL; Link H; Czerkinsky C; Holmgren J
    Int Immunol; 2000 Oct; 12(10):1449-57. PubMed ID: 11007763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
    Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
    Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
    Wang ZY; He B; Qiao J; Link H
    J Neuroimmunol; 1995 Dec; 63(1):79-86. PubMed ID: 8557828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.
    Popovich PG; Yu JY; Whitacre CC
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1323-38. PubMed ID: 9413281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals.
    Miller A; Lider O; Abramsky O; Weiner HL
    Eur J Immunol; 1994 May; 24(5):1026-32. PubMed ID: 7514126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
    J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
    Khoury SJ; Lider O; al-Sabbagh A; Weiner HL
    Cell Immunol; 1990 Dec; 131(2):302-10. PubMed ID: 1700738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
    Jewell SD; Gienapp IE; Cox KL; Whitacre CC
    Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.